rs890

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000834.5(GRIN2B):​c.*409T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.389 in 199,382 control chromosomes in the GnomAD database, including 17,924 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.38 ( 13159 hom., cov: 32)
Exomes 𝑓: 0.42 ( 4765 hom. )

Consequence

GRIN2B
NM_000834.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0780

Publications

54 publications found
Variant links:
Genes affected
GRIN2B (HGNC:4586): (glutamate ionotropic receptor NMDA type subunit 2B) This gene encodes a member of the N-methyl-D-aspartate (NMDA) receptor family within the ionotropic glutamate receptor superfamily. The encoded protein is a subunit of the NMDA receptor ion channel which acts as an agonist binding site for glutamate. The NMDA receptors mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation. Naturally occurring mutations within this gene are associated with neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy, and schizophrenia. [provided by RefSeq, Aug 2017]
GRIN2B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • developmental and epileptic encephalopathy, 27
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • intellectual disability, autosomal dominant 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 12-13562374-A-C is Benign according to our data. Variant chr12-13562374-A-C is described in ClinVar as Benign. ClinVar VariationId is 1281683.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.508 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRIN2BNM_000834.5 linkc.*409T>G 3_prime_UTR_variant Exon 14 of 14 ENST00000609686.4 NP_000825.2 Q13224A0A8D9PHB2
GRIN2BNM_001413992.1 linkc.*409T>G 3_prime_UTR_variant Exon 15 of 15 NP_001400921.1
GRIN2BXM_005253351.3 linkc.*409T>G 3_prime_UTR_variant Exon 4 of 4 XP_005253408.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIN2BENST00000609686.4 linkc.*409T>G 3_prime_UTR_variant Exon 14 of 14 1 NM_000834.5 ENSP00000477455.1 Q13224

Frequencies

GnomAD3 genomes
AF:
0.378
AC:
57427
AN:
151944
Hom.:
13156
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.116
Gnomad AMI
AF:
0.411
Gnomad AMR
AF:
0.484
Gnomad ASJ
AF:
0.516
Gnomad EAS
AF:
0.216
Gnomad SAS
AF:
0.294
Gnomad FIN
AF:
0.434
Gnomad MID
AF:
0.630
Gnomad NFE
AF:
0.513
Gnomad OTH
AF:
0.437
GnomAD4 exome
AF:
0.424
AC:
20070
AN:
47320
Hom.:
4765
Cov.:
0
AF XY:
0.421
AC XY:
10003
AN XY:
23770
show subpopulations
African (AFR)
AF:
0.0884
AC:
129
AN:
1460
American (AMR)
AF:
0.497
AC:
1827
AN:
3674
Ashkenazi Jewish (ASJ)
AF:
0.477
AC:
526
AN:
1102
East Asian (EAS)
AF:
0.209
AC:
599
AN:
2868
South Asian (SAS)
AF:
0.282
AC:
1308
AN:
4642
European-Finnish (FIN)
AF:
0.407
AC:
756
AN:
1858
Middle Eastern (MID)
AF:
0.533
AC:
80
AN:
150
European-Non Finnish (NFE)
AF:
0.473
AC:
13660
AN:
28876
Other (OTH)
AF:
0.441
AC:
1185
AN:
2690
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
520
1041
1561
2082
2602
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
156
312
468
624
780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.378
AC:
57432
AN:
152062
Hom.:
13159
Cov.:
32
AF XY:
0.375
AC XY:
27860
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.115
AC:
4785
AN:
41480
American (AMR)
AF:
0.485
AC:
7407
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.516
AC:
1791
AN:
3470
East Asian (EAS)
AF:
0.216
AC:
1116
AN:
5168
South Asian (SAS)
AF:
0.293
AC:
1412
AN:
4816
European-Finnish (FIN)
AF:
0.434
AC:
4585
AN:
10556
Middle Eastern (MID)
AF:
0.636
AC:
187
AN:
294
European-Non Finnish (NFE)
AF:
0.513
AC:
34855
AN:
67972
Other (OTH)
AF:
0.436
AC:
919
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1619
3238
4857
6476
8095
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
544
1088
1632
2176
2720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.463
Hom.:
51913
Bravo
AF:
0.374
Asia WGS
AF:
0.250
AC:
872
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 24, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 26257337) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.7
DANN
Benign
0.72
PhyloP100
0.078
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs890; hg19: chr12-13715308; API